financetom
Business
financetom
/
Business
/
US Senators Introduce Bill to Ban Direct-to-Consumer Drug Ads
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Senators Introduce Bill to Ban Direct-to-Consumer Drug Ads
Jun 12, 2025 11:12 AM

01:51 PM EDT, 06/12/2025 (MT Newswires) -- US Senators Bernie Sanders and Angus King introduced a bill Thursday to ban direct-to-consumer prescription drug advertising across TV, radio, print, digital and social media.

The "End Prescription Drug Ads Now Act" aims to halt what the senators call misleading and expensive marketing by pharmaceutical companies. The bill aligns with repeated calls from Health and Human Services Secretary Robert Kennedy Jr. to end such advertising, according to a statement from Sanders' Office Thursday.

Sanders said the US and New Zealand are the only countries where pharmaceutical companies can air TV commercials advertising prescription drugs.

King said that widespread pharmaceutical advertising "drives up costs and doesn't necessarily make patients healthier," emphasizing the need for patients to receive information from providers, not biased ads.

Senate data showed that the pharmaceutical industry spent over $5 billion on TV ads last year, including $725 million on just 10 drugs in 2024, despite studies finding that more than half of these ads are misleading or offer little added benefit over existing treatments, according to a statement from Sanders.

Price: 811.59, Change: +2.98, Percent Change: +0.37

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - Alphawave IP Group plc
Form 8.3 - Alphawave IP Group plc
Sep 12, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Form 8.3 - Alphawave IP Group plc
Form 8.3 - Alphawave IP Group plc
Sep 12, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Verition Fund Management LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Form 8.3 - Mural Oncology plc
Form 8.3 - Mural Oncology plc
Sep 12, 2025
LONDON--(BUSINESS WIRE)--   Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if...
Form 8.3 - Dowlais Group plc
Form 8.3 - Dowlais Group plc
Sep 12, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2025 - www.financetom.com All Rights Reserved